Advertisement

Topics

Sanofi Aventis Groupe Company Profile

17:28 EDT 21st September 2017 | BioPortfolio

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).


News Articles [615 Associated News Articles listed on BioPortfolio]

Sanofi-DuoRendite-Aktienanleihe Pro auf Sanofi mit 2,5% Zinsen

Sanofi-DuoRendite-Aktienanleihe Pro auf Sanofi mit 2,5% Zinse Die französische Sanofi (ISIN: FR0000120578) belegt mit über 100.000 Mitarbeitern in mehr als 100 Ländern und einem Umsatz von knapp 3....

Le Groupe Jean Coutu : R?sultats du premier trimestre de l'exercice financier 2018

11 juil. 2017 07h00 HE VARENNES, QUÉBEC--(Marketwired - 11 juillet 2017) -Le Groupe Jean Coutu (PJC) inc. (TSX:PJC.A) (la « Société » ou le Read more...

Mexico watchdog finds big pharma faces no competition on some drugs

MEXICO CITY (Reuters) - Pharmaceutical companies including GlaxoSmithKline, Pfizer and Sanofi-Aventis face no competition for certain drugs in Mexico from generics that are readily available elsewher...

Skin Cancer Treatment Receives Breakthrough Therapy Designation

NewsSanofi, Regeneron: cemiplimab receives FDA 'breakthrough' designation for advanced cutaneous squamous cell carcinoma. The disease is responsible for the most deaths among non-melanoma skin cancer ...

Sanofi-Calls mit 146%-Chance bei Kursanstieg auf 85 EUR

Sanofi-Calls mit 146%-Chance bei Kursanstieg auf 85 EU Laut Analyse von www.godmode-trader.de überzeigten die Zahlen des Pharma Unternehmens Sanofi durchwegs. Dennoch konnte die Sanofi-Aktie (ISIN...

Sanofi finalise l’acquisition de Protein Sciences

Sanofi — Monday, August 28th 2017 at 5:00am UTC  Sanofi finalise l’acquisition de Protein Sciences – Un vaccin antigrippal quadrivalent innovantviendra compléter la gamme de vaccin...

Sanofi: le CHMP recommande l’approbation de l’insuline lispro biosimilaire de Sanofi

Sanofi — Friday, May 19th 2017 at 11:09am UTC Le CHMP recommande l’approbation de l’insuline lispro biosimilaire de Sanofi – Un avis favorable fondé sur les résultats du pro...

Sanofi: Sanofi rated AA by Scope Ratings

Sanofi rated AA by Scope Ratings Paris, France - September 7, 2017 - Sanofi (http://www.sanofi.com/) announced today that the European ratings agency Scope Ratings AG ("Scope") assigned the compan...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema.

To evaluate the safety and efficacy of ziv-aflibercept (Zaltrap; Sanofi-Aventis, Bridgewater, NJ/Regeneron Pharmaceuticals, Tarrytown, NY) in the treatment of refractory diabetic macular edema (DME).

Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine.

Sanofi Pasteur, the manufacturer of the only yellow fever vaccine (YF-VAX) licensed in the United States, has announced that their stock of YF-VAX is totally depleted as of July 24, 2017. YF-VAX for c...

Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.

Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the...

ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

For early-stage Hodgkin lymphoma (HL), optimal chemotherapy regimen and the number of cycles to be delivered remain to settle down. The H9-U trial compared three modalities of chemotherapy followed by...

Sofosbuvir as treatment against dengue?

Dengvaxia(®) (CTD-TDV), the only licensed tetravalent dengue vaccine by Sanofi Pasteur was made available since 2015. However, administration of CTD-TDV in general has not received the prequalificati...

Clinical Trials [98 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

The purpose of this study is to determine bioequivalence of amodiaquine suspension ( Pfizer) and the WHO approved reference product Flavoquine® tablet ( Sanofi Aventis).

Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)

SPECIFIC AIM: To test the safety and feasibility of using low molecular weight heparin (LMWH, enoxaparin sodium; Lovenox, Sanofi-Aventis) in lieu of unfractionated heparin (UFH) as antith...

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

To evaluate the pharmacokinetics of the thromboprophylactic agent enoxaparin in postoperative cardiac surgery patients by comparing plasma anti-Xa activity when enoxaparin is administered ...

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

A randomized, double-blind, placebo-controlled parallel-group study, comparing the bioequivalence of triamcinolone acetonide aqueous nasal spray (Apotex, Inc.) to that of Nasacort® AQ nas...

A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia

The primary objective of the study is to determine whether eszopiclone (Eurofarma) is non-inferior to the reference drug zopiclone (Imovane®, Sanofi-Aventis) in the treatment of insomnia.

Companies [101 Associated Companies listed on BioPortfolio]

Sanofi Aventis Groupe

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SA...

sanofi-aventis U.S.

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. San...

Bristol-Myers Squibb & Sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the l...

Merck and sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Pa...

Sanofi SA

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales.

More Information about "Sanofi Aventis Groupe" on BioPortfolio

We have published hundreds of Sanofi Aventis Groupe news stories on BioPortfolio along with dozens of Sanofi Aventis Groupe Clinical Trials and PubMed Articles about Sanofi Aventis Groupe for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sanofi Aventis Groupe Companies in our database. You can also find out about relevant Sanofi Aventis Groupe Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record